Related Experiment Video

Updated: Mar 20, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K

Optimal antithrombotic treatment in patients with atrial fibrillation and coronary stents: an update

Naoual Bennaghmouch1, Willem J M Dewilde, Jurrien M Ten Berg

  • 1aDepartment of Cardiology, St Antonius Hospital, Nieuwegein bDepartment of Cardiology, Amphia Hospital Breda, Breda, The Netherlands.

Current Opinion in Cardiology
|May 21, 2016
PubMed

Insights

Optimal antithrombotic therapy for atrial fibrillation patients after percutaneous coronary intervention remains unclear. Current evidence suggests dual therapy with oral anticoagulation and clopidogrel may be superior to triple therapy, but more research is needed.

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Optimal antithrombotic therapy for patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) is a complex clinical challenge.
  • Existing guidelines and recent data highlight an underuse of indicated oral anticoagulation in this patient population.
  • Risk assessment tools for guiding treatment decisions, particularly in elderly AF patients, are limited.

Purpose of the Study:

  • To provide an updated review of recent data on antithrombotic therapy for AF patients undergoing PCI.
  • To summarize new evidence regarding the management of this specific patient group.
  • To address the ongoing debate surrounding optimal antithrombotic strategies.

Main Methods:

  • Literature review of recently published studies.
  • Analysis of clinical trial data and observational studies.
  • Synthesis of evidence on antithrombotic regimens and risk stratification.

Main Results:

  • Recent data indicate underutilization of oral anticoagulation in AF patients undergoing PCI when indicated.
  • Dual therapy (oral anticoagulation plus clopidogrel) may offer improved outcomes compared to traditional triple therapy (aspirin, clopidogrel, and oral anticoagulation).
  • Limited data exist on the role of novel oral anticoagulants and newer P2Y12 inhibitors in these regimens.

Conclusions:

  • The optimal antithrombotic strategy for AF patients post-PCI is still not definitively established.
  • Individualized treatment decisions based on careful assessment of both thrombotic and bleeding risks are crucial.
  • Further research is needed to clarify the role of newer agents and refine treatment guidelines, especially for elderly patients.
Abstract

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

704

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
429
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
391
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
569
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
407
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K